Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1789

1.

Parkinson disease.

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE.

Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13. Review.

PMID:
28332488
2.

The dichotomy of the application of a systems approach in UK healthcare the challenges and priorities for implementation.

Pickup L, Lang A, Atkinson S, Sharples S.

Ergonomics. 2017 Mar 24:1-11. doi: 10.1080/00140139.2017.1306632. [Epub ahead of print]

PMID:
28306384
3.

Genome-wide identification and characterization of small RNAs in Rhodobacter capsulatus and identification of small RNAs affected by loss of the response regulator CtrA.

Grüll MP, Peña-Castillo L, Mulligan ME, Lang AS.

RNA Biol. 2017 Mar 15:0. doi: 10.1080/15476286.2017.1306175. [Epub ahead of print]

PMID:
28296577
4.

A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.

Hoff P, Gaber T, Strehl C, Jakstadt M, Hoff H, Schmidt-Bleek K, Lang A, Röhner E, Huscher D, Matziolis G, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Int J Mol Sci. 2017 Mar 8;18(3). pii: E583. doi: 10.3390/ijms18030583.

5.

Revisiting adaptations of neotropical katydids (Orthoptera: Tettigoniidae) to gleaning bat predation.

Ter Hofstede H, Voigt-Heucke S, Lang A, Römer H, Page R, Faure P, Dechmann D.

Neotrop Biodivers. 2017 Jan 1;3(1):41-49. doi: 10.1080/23766808.2016.1272314. Epub 2017 Jan 24.

6.

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE.

Mov Disord. 2017 Mar;32(3):319-324. doi: 10.1002/mds.26913. Epub 2017 Feb 24. Review.

PMID:
28233927
7.

Oculogyric crises: A review of phenomenology, etiology, pathogenesis, and treatment.

Slow EJ, Lang AE.

Mov Disord. 2017 Feb;32(2):193-202. doi: 10.1002/mds.26910. Review.

PMID:
28218460
8.

Peduncolopontine nucleus stimulation in progressive supranuclear palsy: a randomised trial.

Scelzo E, Lozano AM, Hamani C, Poon YY, Aldakheel A, Zadikoff C, Lang AE, Moro E.

J Neurol Neurosurg Psychiatry. 2017 Feb 18. pii: jnnp-2016-315192. doi: 10.1136/jnnp-2016-315192. [Epub ahead of print] No abstract available.

PMID:
28214797
9.

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.

Pleyer L, Döhner H, Dombret H, Seymour JF, Schuh AC, Beach CL, Swern AS, Burgstaller S, Stauder R, Girschikofsky M, Sill H, Schlick K, Thaler J, Halter B, Machherndl Spandl S, Zebisch A, Pichler A, Pfeilstöcker M, Autzinger EM, Lang A, Geissler K, Voskova D, Sperr WR, Hojas S, Rogulj IM, Andel J, Greil R.

Int J Mol Sci. 2017 Feb 15;18(2). pii: E415. doi: 10.3390/ijms18020415.

10.

Adult motor phenotype differentiates Dravet syndrome from Lennox-Gastaut syndrome and links SCN1A to early onset parkinsonian features.

Aljaafari D, Fasano A, Nascimento FA, Lang AE, Andrade DM.

Epilepsia. 2017 Mar;58(3):e44-e48. doi: 10.1111/epi.13692. Epub 2017 Feb 10.

PMID:
28186331
11.

Thyroid Progenitors Are Robustly Derived from Embryonic Stem Cells through Transient, Developmental Stage-Specific Overexpression of Nkx2-1.

Dame K, Cincotta S, Lang AH, Sanghrajka RM, Zhang L, Choi J, Kwok L, Wilson T, Kańduła MM, Monti S, Hollenberg AN, Mehta P, Kotton DN, Ikonomou L.

Stem Cell Reports. 2017 Feb 14;8(2):216-225. doi: 10.1016/j.stemcr.2016.12.024. Epub 2017 Feb 2.

12.

Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.

Coakeley S, Cho SS, Koshimori Y, Rusjan P, Harris M, Ghadery C, Kim J, Lang AE, Wilson A, Houle S, Strafella AP.

J Cereb Blood Flow Metab. 2016 Jan 1:271678X16683695. doi: 10.1177/0271678X16683695. [Epub ahead of print]

PMID:
28155586
13.

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.

Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB.

Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.

14.

Tracking the course of prodromal Parkinson's disease.

Breen DP, Lang AE.

Brain. 2017 Feb;140(Pt 2):259-262. doi: 10.1093/brain/aww321. No abstract available.

PMID:
28137955
15.

Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells.

Zahaf NI, Lang AE, Kaiser L, Fichter CD, Lassmann S, McCluskey A, Augspach A, Aktories K, Schmidt G.

Sci Rep. 2017 Jan 27;7:41252. doi: 10.1038/srep41252.

16.

Essential pitfalls in "essential" tremor.

Espay AJ, Lang AE, Erro R, Merola A, Fasano A, Berardelli A, Bhatia KP.

Mov Disord. 2017 Mar;32(3):325-331. doi: 10.1002/mds.26919. Epub 2017 Jan 24. Review.

PMID:
28116753
17.

Precision medicine for disease modification in Parkinson disease.

Espay AJ, Brundin P, Lang AE.

Nat Rev Neurol. 2017 Feb;13(2):119-126. doi: 10.1038/nrneurol.2016.196. Epub 2017 Jan 20. Review. No abstract available.

PMID:
28106064
18.

Human quarantine: Toward reducing infectious pressure on chimpanzees at the Taï Chimpanzee Project, Côte d'Ivoire.

Grützmacher K, Keil V, Leinert V, Leguillon F, Henlin A, Couacy-Hymann E, Köndgen S, Lang A, Deschner T, Wittig RM, Leendertz FH.

Am J Primatol. 2017 Jan 17. doi: 10.1002/ajp.22619. [Epub ahead of print]

PMID:
28095600
19.

Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.

Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, Balcer LJ, Frohman EM, Prince J, Calabresi PA, Saidha S.

Neurology. 2017 Feb 7;88(6):525-532. doi: 10.1212/WNL.0000000000003582. Epub 2017 Jan 11.

PMID:
28077493
20.

Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.

Visanji NP, Bhudhikanok GS, Mestre TA, Ghate T, Udupa K, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kim S, Azhu Valappil R, Kausar F, Rogaeva E, William Langston J, Tanner CM, Schüle B, Lang AE, Goldman SM, Marras C.

Mov Disord. 2017 Jan 10. doi: 10.1002/mds.26896. [Epub ahead of print]

PMID:
28071824

Supplemental Content

Support Center